296 related articles for article (PubMed ID: 16247185)
1. T-cells in Alzheimer's disease.
Town T; Tan J; Flavell RA; Mullan M
Neuromolecular Med; 2005; 7(3):255-64. PubMed ID: 16247185
[TBL] [Abstract][Full Text] [Related]
2. T-cell brain infiltration and immature antigen-presenting cells in transgenic models of Alzheimer's disease-like cerebral amyloidosis.
Ferretti MT; Merlini M; Späni C; Gericke C; Schweizer N; Enzmann G; Engelhardt B; Kulic L; Suter T; Nitsch RM
Brain Behav Immun; 2016 May; 54():211-225. PubMed ID: 26872418
[TBL] [Abstract][Full Text] [Related]
3. The neuroinflammatory response in plaques and amyloid angiopathy in Alzheimer's disease: therapeutic implications.
Rozemuller AJ; van Gool WA; Eikelenboom P
Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):223-33. PubMed ID: 15975026
[TBL] [Abstract][Full Text] [Related]
4. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
[TBL] [Abstract][Full Text] [Related]
5. Combined treatment of amyloid-β₁₋₄₂-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice.
Wang F; Liu H; Shen X; Ao H; Moore N; Gao L; Chen L; Hu H; Ma H; Yang Z; Zhai C; Qin J; Zhou G; Peng Y; Feng X; Li R; Liang C
Neurobiol Aging; 2015 Jan; 36(1):111-22. PubMed ID: 25085784
[TBL] [Abstract][Full Text] [Related]
6. Abeta-induced meningoencephalitis is IFN-gamma-dependent and is associated with T cell-dependent clearance of Abeta in a mouse model of Alzheimer's disease.
Monsonego A; Imitola J; Petrovic S; Zota V; Nemirovsky A; Baron R; Fisher Y; Owens T; Weiner HL
Proc Natl Acad Sci U S A; 2006 Mar; 103(13):5048-53. PubMed ID: 16549802
[TBL] [Abstract][Full Text] [Related]
7. Active immunotherapy facilitates Aβ plaque removal following through microglial activation without obvious T cells infiltrating the CNS.
Sha S; Xing XN; Cao YP
J Neuroimmunol; 2014 Sep; 274(1-2):62-70. PubMed ID: 25087756
[TBL] [Abstract][Full Text] [Related]
8. Patterns of cerebral amyloid angiopathy define histopathological phenotypes in Alzheimer's disease.
Allen N; Robinson AC; Snowden J; Davidson YS; Mann DM
Neuropathol Appl Neurobiol; 2014 Feb; 40(2):136-48. PubMed ID: 23808763
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of aquaporin expression surrounding senile plaques and cerebral amyloid angiopathy in Alzheimer disease.
Hoshi A; Yamamoto T; Shimizu K; Ugawa Y; Nishizawa M; Takahashi H; Kakita A
J Neuropathol Exp Neurol; 2012 Aug; 71(8):750-9. PubMed ID: 22805778
[TBL] [Abstract][Full Text] [Related]
10. CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide.
Townsend KP; Town T; Mori T; Lue LF; Shytle D; Sanberg PR; Morgan D; Fernandez F; Flavell RA; Tan J
Eur J Immunol; 2005 Mar; 35(3):901-10. PubMed ID: 15688347
[TBL] [Abstract][Full Text] [Related]
11. Targeting the hematopoietic system for the treatment of Alzheimer's disease.
Lampron A; Gosselin D; Rivest S
Brain Behav Immun; 2011 Jun; 25 Suppl 1():S71-9. PubMed ID: 21195165
[TBL] [Abstract][Full Text] [Related]
12. [Current trend of immunotherapy for Alzheimer's disease].
Matsumoto SE; Tabira T
Nihon Rinsho; 2011 Sep; 69(9):1628-32. PubMed ID: 21922765
[TBL] [Abstract][Full Text] [Related]
13. Brain stem hemorrhage due to cerebral amyloid angiopathy: the autopsy of a patient with Alzheimer's disease at a young age.
Ohtani S; Shimizu K; Asari M; Maseda C; Oka K; Yamada H; Hoshina C; Doi H; Yajima D; Shiono H; Ogawa K
Leg Med (Tokyo); 2014 Mar; 16(2):98-101. PubMed ID: 24491518
[TBL] [Abstract][Full Text] [Related]
14. Dense-core senile plaques in the Flemish variant of Alzheimer's disease are vasocentric.
Kumar-Singh S; Cras P; Wang R; Kros JM; van Swieten J; Lübke U; Ceuterick C; Serneels S; Vennekens K; Timmermans JP; Van Marck E; Martin JJ; van Duijn CM; Van Broeckhoven C
Am J Pathol; 2002 Aug; 161(2):507-20. PubMed ID: 12163376
[TBL] [Abstract][Full Text] [Related]
15. N-truncated Aβ2-X starting with position two in sporadic Alzheimer's disease cases and two Alzheimer mouse models.
Savastano A; Klafki H; Haußmann U; Oberstein TJ; Muller P; Wirths O; Wiltfang J; Bayer TA
J Alzheimers Dis; 2016; 49(1):101-10. PubMed ID: 26529393
[TBL] [Abstract][Full Text] [Related]
16. Modeling Alzheimer's disease immune therapy mechanisms: interactions of human postmortem microglia with antibody-opsonized amyloid beta peptide.
Lue LF; Walker DG
J Neurosci Res; 2002 Nov; 70(4):599-610. PubMed ID: 12404514
[TBL] [Abstract][Full Text] [Related]
17. Co-immunization with DNA and protein mixture: a safe and efficacious immunotherapeutic strategy for Alzheimer's disease in PDAPP mice.
Liu S; Shi D; Wang HC; Yu YZ; Xu Q; Sun ZW
Sci Rep; 2015 Jan; 5():7771. PubMed ID: 25586780
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy for Alzheimer's disease.
Solomon B; Frenkel D
Neuropharmacology; 2010; 59(4-5):303-9. PubMed ID: 20388523
[TBL] [Abstract][Full Text] [Related]
19. Strikingly reduced amyloid burden and improved behavioral performance in Alzheimer's disease mice immunized with recombinant chimeric vaccines by hexavalent foldable Aβ₁₋₁₅ fused to toxin-derived carrier proteins.
Yu YZ; Wang WB; Chen A; Chang Q; Liu S; Zhao M; Wang S; Qiu WY; Pang XB; Xu Q; Sun ZW
J Alzheimers Dis; 2014; 41(1):243-60. PubMed ID: 24625800
[TBL] [Abstract][Full Text] [Related]
20. Increased T cell recruitment to the CNS after amyloid beta 1-42 immunization in Alzheimer's mice overproducing transforming growth factor-beta 1.
Buckwalter MS; Coleman BS; Buttini M; Barbour R; Schenk D; Games D; Seubert P; Wyss-Coray T
J Neurosci; 2006 Nov; 26(44):11437-41. PubMed ID: 17079673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
